News Tag: Other Corporate Information

We enter the year with a strong pipeline, an increasing number of inbound requests, and the launch of our new remote care system and display solution – which has been very well received.

Sweden – Growing demand, more procurements, and continued expansion
In Sweden, both interest and market maturity continue to grow. We are now seeing several parallel procurements in addition to the national ADDA tender, a clear indication that medication dispensers have become an integrated part of future healthcare. Several municipalities are also referring to the joint digitalization initiative Handslaget from SKR, which promotes broad implementation of proven welfare technologies – a movement in which Dosell is perfectly aligned.

We continue to maintain strong dialogue with both new and existing municipalities. While lead times are often long due to necessary processes, risk assessments, and anchoring, we are well positioned in many of these. In January, several new quotes and agreement proposals were sent out, and one of our existing customers has already placed a new order for 40 units, along with 15 of our newly launched displays for greater flexibility.

We also conducted five additional digital demonstrations in January and continue to receive new inquiries on an ongoing basis.

The tender submission for Sweden’s first national framework agreement for medication dispensers via ADDA was completed on time by January 5. We also participated in a bid presentation and expect feedback in February. Several municipalities have already signaled their intention to procure Dosell as soon as the agreement is in place.

At the MVTe fair in Stockholm, we launched our remote care platform together with our new modular display. This unique solution makes it possible to use Dosell even for patients who previously could not benefit from a medication dispenser – for example, due to cognitive impairment or a need for more visual guidance.

The response has been very positive. Several municipalities have already requested quotes for the full solution, and we see this as an important complement that can further broaden the target group and increase the value per unit.

Norway – From contract to implementation
Our partnership with Vakt og Alarm has now entered the next phase. The procurement we won with six municipalities began as planned on February 1, and the focus is now on training and implementation. We estimate the initial rollout to include around 100 units and look forward to tracking its progress together with our partner.

The Netherlands – Growth and customer satisfaction
In the Netherlands, our development continues steadily. In January, we signed scale-up agreements with several existing customers and conducted joint evaluations of the implementations. All evaluations confirm high satisfaction, which is also reflected in our latest customer survey: 82.5% of users report being satisfied or very satisfied and would recommend Dosell to others. Several concrete improvement suggestions have been received and are now being implemented.

We have also been contacted by several new potential clients and are engaged in active discussions for pilots and future rollouts. The structural tailwind in the Netherlands is clear – medication dispensers are on their way to becoming the norm in home care, and demand is growing rapidly.

We consider the Netherlands one of our most important markets in Europe. The country has approximately 600,000 patients who receive their medications in dose rolls, compared to around 300,000 in Sweden, which represents a target group twice the size. Additionally, the time from decision to actual implementation is often much shorter than in other countries, offering strong potential for faster growth.

In 2026, we are investing aggressively in the Netherlands by strengthening our local presence. The recruitment of a dedicated Country Manager is in its final stages, with the goal of building a strong local team and scaling the business in pace with sales.

Dosell has also now been approved for inclusion on Digizo.nu – the Dutch national program focused on the broad implementation of proven digital and hybrid care solutions. The program helps healthcare organizations identify effective, validated technologies that deliver real value for patients, users, and professionals. Being listed on Digizo.nu serves as a quality mark, streamlining adoption among new clients and increasing our visibility with both public and private care providers throughout the country.

Iceland – Early-stage groundwork
Preparatory work is underway for a potential market entry in Iceland, where our local partner is engaged in discussions with key stakeholders in both the pharmacy and municipal sectors. There is growing interest in Dosell, and the Icelandic market is characterized by clear national structures, which creates good conditions for coordinated implementation over time.

WHX in Dubai
We are currently participating in the World Health Expo (WHX) in Dubai – the world’s largest healthcare exhibition. The aim of our participation is to meet potential partners and distributors, network with international stakeholders, and identify new opportunities for further expansion.

Looking Ahead – An exciting 2026 has only just begun
We are starting the year with strong momentum and clear visibility. With new markets, stronger solutions, more implementations, and strategic collaborations in place, our focus now is to turn these opportunities into concrete growth. In February, we are prioritizing:

• Securing additional agreements
• Awaiting ADDA allocation decisions
• Starting several planned implementations in February and March
• Continued follow-ups in Norway, Spain, Iceland, and Finland

Thank you for following our journey!

The new Display is a modular add-on that enables Dosell’s functionality to be scaled over time. The Display can be mounted directly on Dosell, placed next to the unit, or used completely standalone, even in another room. When the Display is not required, Dosell can be used as a standalone solution, and when needs change, the Display can easily be added or removed.

This allows municipalities and care providers to standardize on a single medication dispensing device while adapting the level of functionality to individual user needs. For users who require additional support, the Display can provide clear information on upcoming doses, reminders for other medications, and the option for video calls with care staff. For other users, Dosell in its base configuration is sufficient.

At the same time, iZafe is launching a new remote care system that brings administration, monitoring, and communication together in a unified digital platform. Through a web-based administration interface, care organizations gain an overview of all Dosell units, alarms, events, historical data, adherence information, and user and access management with full traceability and logging. The system is complemented by mobile app and web access, enabling authorized staff to securely access assigned Dosell units, view upcoming doses, manage alarms, review history, and conduct video calls.

Video calls enable a new and more flexible way of working with medication management. In certain situations, medication intake can take place in connection with a video call, allowing care staff to visually confirm that the medication is taken. This is a selectable support function, intended for cases where increased supervision and reassurance are needed.

“With this launch, we remove a common trade-off in medication dispensing – choosing between simpler or more advanced devices. Instead, we offer a flexible solution where the same Dosell can be used for all users and complemented with a Display as needs evolve. This gives municipalities and care providers a completely different level of long-term efficiency and adaptability,” says Anders Segerström, CEO of iZafe Group AB.

The launch marks a strategic step in the evolution of Dosell from a standalone product into a modular platform that can be adapted over time. The solution supports different levels of supervision and independence and aligns with the ongoing shift toward increased remote care and more efficient use of resources in healthcare and social care.

More information about the Display and the new remote care system is available at:
https://display.dosell.com/

The Display and the remote care system will be made available gradually during 2026, initially as optional add-ons, in new deliveries, and through pilot projects in selected markets. Additional functionality is planned to be introduced continuously.

This is a technical and functional product launch. Commercial impact will depend on customer needs, procurement processes, and implementation pace.

iZafe Group is exhibiting at the MVTe trade fair at booth I24 and welcomes visitors who wish to experience the solution firsthand.

The summer and autumn were characterized by continued development, including acquisitions, new integrations, and several new markets gaining momentum. We continue to see a positive development in our recurring revenue model, which is a key indicator that the business model is scaling as planned. The company remains committed to consistent and transparent reporting, and to ensure accurate and equal disclosure of information, the final full-year ARR outcome will be reported in connection with the next quarterly report.

Sweden – A Powerful Growth Journey
During 2025, we have seen exceptional development in the Swedish market. From four municipalities at the beginning of the year to more than 30 in operation by year-end, representing growth of over 700 percent. Municipalities that initially started with pilot projects have transitioned to full-scale implementation, and references from existing customers have played a decisive role in driving broader adoption.

In December, two new municipalities went live, and we close the year with several additional municipalities planned for launch in the first quarter of 2026. In addition, more than ten contract proposals have been submitted for upcoming deployments in the coming months.

We have also submitted our bid in Sweden’s first national framework agreement procurement for medication dispensing robots (ADDA), with a deadline of January 5. The framework agreement is estimated to have a value of up to SEK 200 million per year and is expected to enable simplified procurement processes for municipalities starting in 2026. With the strong foothold established during 2025, Dosell is well positioned to play a leading role within this framework.

The Netherlands – Acquisition, Growth, and Local Strength
In 2025, we acquired our former distributor in the Netherlands, which is now a wholly owned subsidiary. The Dutch team has continued to grow throughout the autumn and winter, with both new customers and increased volumes among existing customers.

Our local presence contributes to improved onboarding, stronger customer relationships, and more efficient technical integration. Insights gained from the Netherlands, Europe’s most mature market for medication dispensing robots, provide valuable expertise that is now being leveraged in our broader European expansion.

Spain and Southern Europe – Long-Term Opportunities
In Spain, together with our partner Ti Medi, we have initiated a consumer-focused pilot through pharmacies. During December, Dosell was physically available in selected pharmacies, allowing customers to easily start their subscription.

This initiative is long-term in nature. The concept of medication dispensing robots is still relatively new in Spain, and time as well as market education are required before larger volumes can be achieved. The positive aspect is that the concept is now being tested in real-world conditions, and our partner has also introduced Dosell in Portugal and is planning the next steps in Italy.

Finland – Ready for Rollout
In Finland, together with our partner AddSecure, we have finalized technical integration, training, and documentation. At KOPA 2025, the country’s largest event for home care and assisted living, we experienced strong interest and received the same clear feedback as in previous engagements.

We are now ready to initiate a broader rollout in Finland, targeting both private and public sector stakeholders.

Norway and Iceland – New Markets Taking Shape
In November, we announced our first successful public procurement in Norway together with our partner Vakt og Alarm. The agreement covers six municipalities with planned deployments starting on February 1, 2026, marking the beginning of our expansion into another Nordic market.

In Iceland, we have launched a new collaboration with a local partner operating in both the public sector and direct-to-consumer channels. The establishment phase has begun, and we see favorable conditions for building a presence in this market as well.

December – A Strong Finish to a Strong Year
Key highlights of the month:

• Two new municipal deployments in Sweden
• Several new municipal contracts signed ahead of Q1
• Consumer pilot launched via pharmacies in Spain
• Preparations for market launches in Norway and Iceland
• Additional healthcare organizations going live in the Netherlands
• Completion of the ADDA procurement submission
• Continued expansion across the entire partner network

2026 – Continued Focus on Growth and Visibility
We enter 2026 with strong momentum. During the first quarter, we will participate in the MVTe trade fair in Stockholm, where we will meet Swedish municipalities and decision-makers within health and social care.

We are also pleased to be part of the Swedish delegation to the World Health Expo in Dubai, where we will present both Dosell and Pilloxa to potential partners, distributors, and decision-makers in the MENA region.

Thank You for Your Trust – Building for the Future
We are still a small but highly dedicated team. What has been built during 2025 demonstrates what is possible with the right strategy and focused execution.

Thank you to all customers, partners, and shareholders who are part of our journey.

We continue to build the future of medication management.
And we are only at the beginning.

We are now working intensively to deliver as many Dosell units as possible before year-end. Each delivery contributes directly to our recurring revenue and is therefore central to meeting our communicated forecasts.

Sweden – More Municipal Rollouts, Strong Network Effects
Two additional municipalities launched Dosell in November, both with highly positive outcomes in a short time. One municipality has already placed an additional order for 15 units, clearly showing how the user experience translates quickly into concrete demand.

As we’ve heard before, the feedback has once again been unanimous:
“It’s so user-friendly to operate, it meets all our needs, and the lightweight design is a big plus!”

In addition, five more municipalities have signed agreements to launch Dosell in December and January. During November, we also presented Dosell to 14 new municipalities, and we’re seeing a strong network effect — more and more reference their neighboring municipalities using Dosell and share positive feedback, which strengthens both our credibility and our pipeline going into 2026.

Norway – First Public Procurement Won
Together with our new partner Vakt og Alarm, we have now won a public procurement in Norway that will bring Dosell to six municipalities starting February 1. This marks an important step in our ambition to establish ourselves in the Norwegian market in 2026, much like we have successfully done in Sweden this year.

Finland – Strong Presence and Growing Awareness
In November, we participated in KOPA 2025, Finland’s largest trade fair for municipal home care and assisted living, together with our partner AddSecure. This gave us the opportunity to present Dosell to a wide range of decision-makers and once again, the response was clear:
“This is exactly the kind of solution we’ve been missing in Finland.”

We have now finalized all technical preparations for launch, including integration with UMO/Enovation, training, and workflow configurations. We are fully ready to begin broader rollouts together with AddSecure, with a tested and integrated technical environment in place.

Iceland – New Market, Strong Partner
In November, we launched our new partnership with Skand in Iceland. Our new partner will work with both public and private sector stakeholders (B2B), as well as directly with consumers (B2C). Skand is a well-established player with strong drive and high ambitions, and we look forward to establishing Dosell in another new market where interest is already evident.

The Netherlands – Continued Growth After the Acquisition
Our Dutch subsidiary continues to grow steadily, and the integration is moving ahead rapidly. The team is working closely with both existing and new customers, and in November we increased the number of active units and initiated deployments with several new care organizations. This growth reaffirms Dosell’s strong position in the Dutch market.

We are simultaneously driving multiple improvement initiatives in packaging, installation, and system integrations — all aimed at enhancing user experience and streamlining implementation. Our local presence continues to prove a strategic advantage, creating business value and strengthening customer relationships. Insights from the Netherlands are already proving valuable as we scale in other European markets.

ADDA – Procurement Reissued
The ADDA procurement process has been reissued following minor revisions — something that is common in larger framework agreements. The new deadline for submissions is January 5. For us, this is simply a shift in timing. Our work continues as planned, and several municipalities have already signaled their intention to procure Dosell once the agreement is in place.

Looking Ahead – A Strong Finish to the Year
As we enter the final month of the year, our focus is on delivering according to plan. On the agenda:

• New municipal implementations
• Rollout in five new municipalities in Sweden
• Preparations for first customers in Norway (launching February 1)
• Launch of Dosell in Iceland – both B2B and B2C
• Continued growth in the Netherlands – new customers and more units
• Ongoing pilot discussions and presentations in Sweden
• Final submission for the ADDA procurement (January 5)
• Ongoing technical integrations and support
• Follow-up from the KOPA trade fair in Finland

Thank You for Your Support – We’re Just Getting Started
We remain a small but highly dedicated team, and our strategy is clearly delivering results. With over 30 municipalities now using Dosell in Sweden, operations launched in five European countries, and a growing stream of new customers and deals, we head into 2026 with both momentum and direction.

Thank you for following our journey.
Together, we are building the future of medication management.

The purchase follows an additional acquisition of 100,000 shares made in October. After the latest transaction, Anna Håkansson’s total holding, via her company, amounts to 250,000 shares in iZafe Group.

Anna Håkansson was elected to the Board at this year’s Annual General Meeting.

“I have chosen to increase my shareholding as I see a clear direction for the company and strong potential in the journey we are now undertaking,” says Anna Håkansson, Board Member of iZafe Group.

The partnership builds on Dosell’s existing integration with the UMO platform and the upcoming transition to the next-generation UMOcx. This enables fast, secure, and scalable implementation in Norwegian municipalities and meets the growing need for safe and digitalized medication management across the country.

As an early confirmation of the partnership’s strength, iZafe Group and Vakt og Alarm have already secured their first joint procurement in Norway. The procurement covers six municipalities with an initial volume of approximately 100 Dosell units. This represents a significant first deal and an important reference for the continued expansion in the Norwegian market.

The standstill period runs until 28 November, and the agreement is scheduled to enter into force on 1 February 2026.

This initial success clearly demonstrates that iZafe Group’s strategy – combining deep technical integration with strong local presence through partners – is already delivering tangible results in the early stages of the company’s expansion in Norway.

– “We are pleased to initiate this collaboration with iZafe Group and see Dosell as a valuable addition to our range of safety solutions. With Dosell, we can offer our customers a proven and user-friendly solution for secure medication management – fully aligned with our mission to contribute to a safer everyday life for both users and care staff,” says Lillian S Lien, CEO of Vakt og Alarm AS.

With this first joint deal, iZafe Group and Vakt og Alarm are laying the foundation for a long-term and expanding collaboration in Norway. The procurement clearly shows how Dosell can be rapidly implemented and scaled within Norwegian care services and marks the beginning of a broader market establishment.

About Vakt og Alarm
Vakt og Alarm AS was founded in 1990 and is a leading Norwegian provider of safety and alarm services for the care and welfare sector. The company has delivered solutions to more than 250 municipalities across Norway and is headquartered in Etne. With an experienced team and a strong focus on quality and availability, Vakt og Alarm contributes to increased safety for both users and care staff throughout the country.

Skand is an established player in medical technology and health services in Iceland, with team that has extensive experience in introducing innovative solutions within both the public and private healthcare sectors. Through this partnership, iZafe Group gains a locally rooted distributor with strong reach into professional care providers as well as the consumer market, creating solid conditions for broad and long-term market penetration.
 
As part of the agreement, Skand has placed an initial order of 300 Dosell units, with delivery scheduled during 2026. This volume is expected to generate an annual recurring revenue (ARR) of approximately SEK 2–3 million when fully activated, depending on the distribution between B2B and B2C.
 
Iceland is characterized by a high degree of digitalization and a strong focus on patient safety and efficient care processes. A recent analysis estimates that around 8,700 people in Iceland receive their medications in pouch packaging, corresponding to just over 13% of the country’s elderly population.
 
Skand has developed a launch plan that combines implementation within healthcare and home care with initiatives aimed at the consumer market. This two-track strategy enables Dosell to be introduced broadly and scalably in Iceland without depending on a single market channel.
 
Public healthcare and home care
The launch begins with selected collaborations within healthcare and home care to establish local reference cases and demonstrate the quality and efficiency gains Dosell provides. The focus is on improved adherence, increased safety and reduced workload for care staff.
 
Consumer and pharmacy market
In parallel, Dosell will be introduced through established sales channels targeting consumers and relatives. Skand´s team has long experience in launching medical technology products in these channels, creating favourable conditions for rapid commercialization and broader market reach.
 
“We are very pleased to enter into this collaboration with Skand. Iceland is a market with a high level of innovation and a clear focus on patient safety. With Skand’s local presence and experience, we see strong potential to establish Dosell as a leading solution both in the home and within the healthcare sector. This is another important step in our Nordic expansion strategy,” says Anders Segerström, CEO of iZafe Group.
 
“Dosell represents the future of medication management, and we are excited to deliver this innovation to the Icelandic market. Together with iZafe Group, we aim to make daily life safer and easier for patients, families, and healthcare professionals nationwide”, says Bergur Bergsson CEO of Skand ehf.

The acquisitions underline Helena’s strong commitment to iZafe Group’s operations and her confidence in the company’s continued development and growth. Following the transactions, Helena’s total holding amounts to 297,328 B-shares.

“I see how hard our team works every day, how quickly we are developing, and the strong potential in our market. We are in a very exciting phase, and for me, it feels natural to increase my ownership when I see the direction and opportunities ahead of us.” says Helena Kolvik, Business Unit Manager at iZafe Group.

Sweden – Growing customer base, new pilots and increased visibility
We now have more than 20 Swedish municipalities using or actively testing Dosell – and interest continues to grow month by month. In October,
Several municipalities signed new pilot agreements during the month, scheduled to begin in November and December. We are also seeing increased interest from nursing homes (SÄBO), where Dosell is viewed as a concrete solution to reduce medication errors and strengthen residents’ independence.

To meet the growing demand, we have recruited two new salespeople focusing on the municipal and private care sectors. Their role is to support implementation, follow up on leads and drive continued expansion.

Meanwhile, the ADDA procurement process – Sweden’s first national framework agreement for medication dispensing robots – is now in its final phase. The estimated annual contract value of SEK 200 million highlights a maturing market and confirms Dosell’s strong position heading into 2026.

The Netherlands – Integration and continued growth
Following the acquisition of Thuisapparatuur Nederland B.V., our focus has been on fully integrating operations into the Group. The Dutch team has maintained close customer engagement, participated in fairs, onboarded a new customer, and increased volumes with existing ones. We have also initiated new platform integrations and are working on improved packaging to further enhance the user experience.

Dosell is currently in use across more than 30 care organisations in the Netherlands – Europe’s most mature market for medication dispensing robots. Yet growth potential remains significant: over 600,000 people in the country receive medications in pouch packaging, but only around 17,000 medication dispensers are currently in operation. Our solution, developed in this complex environment, is now both technically advanced and highly user-friendly – positioning us strongly to lead the next phase of market growth.

Finland – Strong interest and technical readiness
Together with our partner AddSecure, we have completed all preparatory work ahead of the rollout to existing customers. This includes full integration with the leading UMO/Enovation care platform, training materials, system flows, and pilot testing.

Interest from both private care providers and public welfare areas is very high – Dosell is seen as a concrete and sought-after solution to improve adherence, reduce deviations, and free up time for care staff.
Next week, we will participate in Finland’s largest home care and assisted living trade fair – KOPA 2025 – together with AddSecure, further strengthening our local presence and enabling key customer dialogues.

Spain – Pharmacy launch with Ti Medi
In Spain, we are taking the next step together with our partner Ti Medi, who collaborates with over 1,600 pharmacies that serve more than 200,000 patients receiving pouch-packed medications.

In November, we are launching an initial pilot across approximately 10 pharmacies where Dosell will be physically available in-store. Customers can easily bring Dosell home and register their subscription digitally. The launch will be supported by Black Friday and holiday campaigns, with the goal of establishing a new, safe, and accessible solution for home-based medication management.

The concept of medication dispensers is new to the Spanish market, but with Ti Medi as our partner, we have strong local reach and the right channels to engage both patients and families.
They have also begun promoting the concept in their operations in Portugal and France, where Dosell is now being introduced via trade fairs and local initiatives. The next step will be Italy, where a similar rollout is planned.

Finance & Forecast – On track
Our financial performance in Q3 shows that we’ve established a stable and scalable business model based on recurring revenues. At the beginning of Q4, our ARR reached approximately SEK 7 million – a fourfold increase since the start of the year – and we remain on track to meet our target of SEK 10 million ARR during Q4. The recently acquired Dutch company generated approximately SEK 1 million in revenue during Q3, which was not consolidated but will contribute from Q4 onwards.

At the same time, we’ve improved our cost structure, strengthened cash flow, and created a better foundation for long-term profitable growth. EBITDA improved significantly compared to the same period last year, despite lower overall revenues – a clear sign of increased operational efficiency.

Looking ahead – Key focus areas through year-end
We are now entering the most intense period of the year. Our focus for November and December includes:

• Finalisation and submission of the ADDA procurement (deadline: 10 November)
• Onboarding of additional municipalities in Sweden
• Expanded outreach to nursing homes (SÄBO) and broader engagement with the private care sector
• Continued product demos and pilot discussions with municipalities
• Ongoing integration and coordination of operations in the Netherlands
• Launch and evaluation of the pharmacy pilot in Spain
• Continued dialogue with new potential partners across Europe

Thank you for your trust – building the future of medication management
We are still a small team – but a highly dedicated one. With a stronger offering, growing recurring revenues, and rapid international expansion, we are entering 2026 with the right conditions to continue delivering – both in the market and toward our strategic goals.

Thank you for following our journey.
We’re only just getting started.